Private Advisor Group’s Medicus Pharma MDCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-240,055
Closed -$110K 2952
2026
Q1
$110K Buy
240,055
+64,560
+37% +$67.4K ﹤0.01% 2522
2025
Q4
$269K Buy
175,495
+23,995
+16% +$51.4K ﹤0.01% 2226
2025
Q3
$351K Buy
151,500
+5,500
+4% +$13.8K ﹤0.01% 1980
2025
Q2
$437K Buy
146,000
+89,250
+157% +$356K ﹤0.01% 1754
2025
Q1
$211K Buy
+56,750
New +$178K ﹤0.01% 2076

Other funds holding MDCX

Private Advisor Group's MDCX Position: Q2 2026 in Review

Private Advisor Group sold out of Medicus Pharma (MDCX) in Q2 2026, closing a stake of 240,055 shares — an estimated $110K sold.

Private Advisor Group first reported a position in MDCX in Q1 2025 and held it in 5 quarters. The position peaked at $437K in Q2 2025. 23 funds tracked by Wall St. Rank hold MDCX as of Q2 2026.

  • Private Advisor Group reported no remaining Medicus Pharma position as of Q2 2026 after selling out during the quarter.
  • Private Advisor Group sold 240,055 Medicus Pharma shares in Q2 2026, an estimated $110K.
  • Private Advisor Group first reported a position in Medicus Pharma in Q1 2025 and held it in 5 quarters.
  • Private Advisor Group's Medicus Pharma position peaked at $437K in Q2 2025.
  • 23 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.